{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:47:23Z","timestamp":1791892043302,"version":"4.3.4"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-026-01235-8","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:24:34Z","timestamp":1791555874000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mechanistic attenuation by L-carnitine of trastuzumab-induced downregulation of adenosine monophosphate -activated protein kinase signal in cardiac H9c2 cells"],"prefix":"10.1186","volume":"27","author":[{"given":"Yasmin M.","family":"Attia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel-Moneim M.","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad","family":"Shash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May","family":"Elgazzar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"Sharaky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawaz E.","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed M.","family":"Sayed-Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riham M.","family":"Karkeet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"issue":"2","key":"1235_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-022-00579-0","volume":"22","author":"SM Swain","year":"2023","unstructured":"Swain SM, Shastry M, Hamilton E. Targeting HER2-positive breast cancer: advances and future directions. Nat Rev Drug DiscovNat Rev Drug Discov. 2023, Feb;22(2):101\u201326. https:\/\/doi.org\/10.1038\/s41573-022-00579-0. Epub 2022 Nov 7. PMID: 36344672; PMCID: PMC9640784.","journal-title":"Nat Rev Drug DiscovNat Rev Drug Discov"},{"issue":"3","key":"1235_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.21037\/atm-23-153","volume":"12","author":"JT J\u00f8rgensen","year":"2024","unstructured":"J\u00f8rgensen JT. Twenty-five years with HER2 targeted therapy. Ann Transl Med. 2024, Jun, 10;12(3):53. https:\/\/doi.org\/10.21037\/atm-23-153. Epub 2023 Jun 25. PMID: 38911570; PMCID: PMC11193558.","journal-title":"Ann Transl Med"},{"issue":"13","key":"1235_CR3","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1056\/NEJMcibr1909386","volume":"381","author":"DF Hayes","year":"2019","unstructured":"Hayes DF. HER2 and breast cancer - a phenomenal success story. NEJM Evid. 2019, Sep, 26;381(13):1284\u201386. https:\/\/doi.org\/10.1056\/NEJMcibr1909386. Epub 2019 Sep 10. PMID: 31502769.","journal-title":"NEJM Evid"},{"issue":"2","key":"1235_CR4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10549-022-06678-1","volume":"195","author":"HG Kaplan","year":"2022","unstructured":"Kaplan HG, Malmgren JA, Guo B, Atwood MK. Trastuzumab therapy duration in HER2-positive de novo metastatic breast cancer: 1999-2018. Breast Cancer Res Treat. 2022, Sep;195(2):171\u201380. https:\/\/doi.org\/10.1007\/s10549-022-06678-1. Epub 2022 Jul 22. PMID: 35869377; PMCID: PMC9374606.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"1235_CR5","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/tbj.12412","volume":"21","author":"B Pistilli","year":"2015","unstructured":"Pistilli B, Marcellusi A, Latini L, Accardi R, Ferretti B, Benedetti G. Cardiotoxicity related to long-term trastuzumab therapy in metastatic breast cancer: the potential role of treatment duration and cardiac risk factors. The Breast J. 2015, May-Jun;21(3):318\u201321. https:\/\/doi.org\/10.1111\/tbj.12412. Epub 2015 Mar 19. PMID: 25790346.","journal-title":"The Breast J"},{"issue":"1","key":"1235_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10741-018-9731-y","volume":"24","author":"PM Kostakou","year":"2019","unstructured":"Kostakou PM, Kouris NT, Kostopoulos VS, Damaskos DS, Olympios CD. Cardio-oncology: a new and developing sector of research and therapy in the field of cardiology. Heart Fail Rev. 2019, Jan;24(1):91\u2013100. https:\/\/doi.org\/10.1007\/s10741-018-9731-y. PMID: 30073443.","journal-title":"Heart Fail Rev"},{"issue":"3","key":"1235_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s12609-017-0249-4","volume":"9","author":"S Nowsheen","year":"2017","unstructured":"Nowsheen S, Viscuse PV, O\u2019sullivan CC, Sandhu NP, Haddad TC, Blaes A, et al. Incidence, diagnosis, and treatment of cardiac toxicity from Trastuzumab in patients with breast cancer. Curr Breast Cancer Rep. 2017, Sep;9(3):173\u201382. https:\/\/doi.org\/10.1007\/s12609-017-0249-4. Epub 2017 Jul 14. PMID: 29225726; PMCID: PMC5718359.","journal-title":"Curr Breast Cancer Rep"},{"issue":"1","key":"1235_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11739-015-1362-x","volume":"11","author":"S Mantarro","year":"2016","unstructured":"Mantarro S, Rossi M, Bonifazi M, D\u2019amico R, Blandizzi C, La Vecchia C, et al. Risk of severe cardiotoxicity following treatment with trastuzumab: a meta-analysis of randomized and cohort studies of 29, 000 women with breast cancer. Intern Emerg Med. 2016, Feb;11(1):123\u201340. https:\/\/doi.org\/10.1007\/s11739-015-1362-x. Epub 2015 Dec 28. PMID: 26712595.","journal-title":"Intern Emerg Med"},{"issue":"33","key":"1235_CR9","doi-asserted-by":"publisher","first-page":"4222","DOI":"10.1200\/JCO.2013.48.7884","volume":"31","author":"M Chavez-MacGregor","year":"2013","unstructured":"Chavez-MacGregor M, Zhang N, Buchholz TA, Zhang Y, Niu J, Elting L, et al. Trastuzumab-related cardiotoxicity among older patients with breast cancer. J Clin Oncol. 2013, Nov, 20;31(33):4222\u201328. https:\/\/doi.org\/10.1200\/JCO.2013.48.7884. Epub 2013 Oct 14. PMID: 24127446; PMCID: PMC3821011.","journal-title":"J Clin Oncol"},{"issue":"9","key":"1235_CR10","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1093\/annonc\/mdt182","volume":"24","author":"A Schneeweiss","year":"2013","unstructured":"Schneeweiss A, Chia S, Hickish T, Harvey V, Eniu A, Hegg R, et al. Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA). Ann Oncol. 2013, Sep;24(9):2278\u201384. https:\/\/doi.org\/10.1093\/annonc\/mdt182. Epub 2013 May 22. PMID: 23704196.","journal-title":"Ann Oncol"},{"issue":"11","key":"1235_CR11","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1056\/NEJM200103153441101","volume":"344","author":"DJ Slamon","year":"2001","unstructured":"Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med. 2001, Mar, 15;344(11):783\u201392. https:\/\/doi.org\/10.1056\/NEJM200103153441101. PMID: 11248153.","journal-title":"N Engl J Med"},{"issue":"31","key":"1235_CR12","doi-asserted-by":"publisher","first-page":"7820","DOI":"10.1200\/JCO.2005.13.300","volume":"23","author":"MS Ewer","year":"2005","unstructured":"Ewer MS, Vooletich MT, Durand JB, Woods ML, Davis JR, Valero V, et al. Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment. J Clin Oncol. 2005, Nov, 1;23(31):7820\u201326. https:\/\/doi.org\/10.1200\/JCO.2005.13.300. PMID: 16258084.","journal-title":"J Clin Oncol"},{"key":"1235_CR13","doi-asserted-by":"publisher","unstructured":"Zhou S, Cirne F, Chow J, Zereshkian A, Bordeleau L, Dhesy-Thind S, et al. Three-year outcomes following permissive cardiotoxicity in patients on trastuzumab. Oncologist. 2023, September;28(9):e712\u201322. https:\/\/doi.org\/10.1093\/oncolo\/oyad086.","DOI":"10.1093\/oncolo\/oyad086"},{"key":"1235_CR14","doi-asserted-by":"publisher","unstructured":"ElZarrad MK, Mukhopadhyay P, Mohan N, Hao E, Dokmanovic M, Hirsch DS, et al. Trastuzumab alters the expression of genes essential for cardiac function and induces ultrastructural changes of cardiomyocytes in mice. PLoS One. 8(11):e79543. https:\/\/doi.org\/10.1371\/journal.pone.0079543. 2013 Nov 8. Erratum in:PLoS One. 2014, 9(1):10.1371\/annotation\/3ba18ef8-8c9c-45ab-9bc5-ad571a54a28c. PMID: 24255707; PMCID: PMC3821852.","DOI":"10.1371\/journal.pone.0079543"},{"issue":"6","key":"1235_CR15","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1158\/1535-7163.MCT-15-0741","volume":"15","author":"N Mohan","year":"2016","unstructured":"Mohan N, Shen Y, Endo Y, ElZarrad MK, Wu WJ. Trastuzumab, but not Pertuzumab, dysregulates HER2 signaling to mediate inhibition of autophagy and increase in reactive oxygen species production in human cardiomyocytes. Mol Cancer Ther. 2016, Jun;15(6):1321\u201331. https:\/\/doi.org\/10.1158\/1535-7163.MCT-15-0741. Epub 2016 Mar 29. PMID: 27197303.","journal-title":"Mol Cancer Ther"},{"issue":"7647","key":"1235_CR16","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/nature21408","volume":"543","author":"Z Keckesova","year":"2017","unstructured":"Keckesova Z, Donaher JL, De Cock J, Freinkman E, Lingrell S, Bachovchin DA, et al. LACTB is a tumour suppressor that modulates lipid metabolism and cell state. Nature. 2017, Mar, 30;543(7647):681\u201386. https:\/\/doi.org\/10.1038\/nature21408. Epub 2017 Mar 22. PMID: 28329758; PMCID: PMC6246920.","journal-title":"Nature"},{"issue":"1","key":"1235_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1432-1033.1997.00001.x","volume":"244","author":"JD McGarry","year":"1997","unstructured":"McGarry JD, Brown NF. The mitochondrial carnitine palmitoyltransferase system \u2014 from concept to molecular analysis. Eur J Biochem. 1997, Feb, 15;244(1):1\u201314. https:\/\/doi.org\/10.1111\/j.1432-1033.1997.00001.x. PMID: 9063439.","journal-title":"Eur J Biochem"},{"issue":"9","key":"1235_CR18","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3389\/fonc.2019.01201","volume":"9","author":"S Han","year":"2019","unstructured":"Han S, Wei R, Zhang X, Jiang N, Fan M, Huang JH, et al. CPT1A\/2-mediated FAO enhancement-A metabolic target in radioresistant breast cancer. Front Oncol. 2019, Nov;9(9):1201. https:\/\/doi.org\/10.3389\/fonc.2019.01201. PMID: 31803610; PMCID: PMC6873486.","journal-title":"Front Oncol"},{"issue":"1","key":"1235_CR19","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1186\/s12885-018-4626-9","volume":"18","author":"A Aiderus","year":"2018","unstructured":"Aiderus A, Black MA, Dunbier AK. Fatty acid oxidation is associated with proliferation and prognosis in breast and other cancers. BMC Cancer. 2018, Aug, 9;18(1):805. https:\/\/doi.org\/10.1186\/s12885-018-4626-9. PMID: 30092766; PMCID: PMC6085695.","journal-title":"BMC Cancer"},{"issue":"1","key":"1235_CR20","doi-asserted-by":"publisher","first-page":"6587","DOI":"10.1038\/s41467-024-50998-3","volume":"15","author":"I Nandi","year":"2024","unstructured":"Nandi I, Ji L, Smith HW, Avizonis D, Papavasiliou V, Lavoie C, et al. Targeting fatty acid oxidation enhances response to HER2-targeted therapy. Nat CommunicationsNat Commun. 2024, Aug, 3;15(1):6587. https:\/\/doi.org\/10.1038\/s41467-024-50998-3. PMID: 39097623; PMCID: PMC11297952.","journal-title":"Nat CommunicationsNat Commun"},{"issue":"1","key":"1235_CR21","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12970-020-00377-2","volume":"17","author":"AK Sawicka","year":"2020","unstructured":"Sawicka AK, Renzi G, Olek RA. The bright and the dark sides of L-carnitine supplementation: a systematic review. J Int Soc Sports nutr. 2020, Sep, 21;17(1):49. https:\/\/doi.org\/10.1186\/s12970-020-00377-2. PMID: 32958033; PMCID: PMC7507632.","journal-title":"J Int Soc Sports nutr"},{"issue":"7","key":"1235_CR22","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.bcp.2012.12.021","volume":"85","author":"S Zambrano","year":"2013","unstructured":"Zambrano S, Blanca AJ, Ruiz-Armenta MV, Miguel-Carrasco JL, Ar\u00e9valo M, V\u00e1zquez MJ, et al. L-Carnitine protects against arterial hypertension-related cardiac fibrosis through modulation of PPAR-\u03b3 expression. Biochemical Pharmacol. 2013, Apr, 1;85(7):937\u201344. https:\/\/doi.org\/10.1016\/j.bcp.2012.12.021. Epub 2013 Jan 4. PMID: 23295156.","journal-title":"Biochemical Pharmacol"},{"key":"1235_CR23","doi-asserted-by":"publisher","unstructured":"Song X, Qu H, Yang Z, Rong J, Cai W, Zhou H. Efficacy and safety of L-Carnitine treatment for chronic heart failure: a meta-analysis of randomized controlled trials. BioMed research International. 2017;2017:6274854. https:\/\/doi.org\/10.1155\/2017\/6274854. Epub 2017 Apr 13. PMID: 28497060; PMCID: PMC5406747.","DOI":"10.1155\/2017\/6274854"},{"issue":"1","key":"1235_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1320.001","volume":"1033","author":"DW Foster","year":"2004","unstructured":"Foster DW. The role of the carnitine system in human metabolism. Ann New Y Acad Sci. 2004, Nov;1033(1):1\u201316. https:\/\/doi.org\/10.1196\/annals.1320.001. PMID: 15590999.","journal-title":"Ann New Y Acad Sci"},{"key":"1235_CR25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2147\/VHRM.S14356","volume":"28","author":"MD Herrera","year":"2011","unstructured":"Herrera MD, Rodr\u00edguez-Rodr\u00edguez M, Justo R, Luisa Justo M, Sotomayor DE. Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders. Vasc Health Risk Manag. 2011, Mar;28:169\u201376. https:\/\/doi.org\/10.2147\/VHRM.S14356.","journal-title":"Vasc Health Risk Manag"},{"issue":"11","key":"1235_CR26","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.3390\/nu15112587","volume":"15","author":"A Caballero-Garc\u00eda","year":"2023","unstructured":"Caballero-Garc\u00eda A, Noriega-Gonz\u00e1lez DC, Roche E, Drobnic F, C\u00f3rdova A. Effects of L-Carnitine intake on exercise-induced muscle damage and oxidative stress: a narrative scoping review. Nutrients. 2023, May, 31;15(11):2587. https:\/\/doi.org\/10.3390\/nu15112587.","journal-title":"Nutrients"},{"key":"1235_CR27","doi-asserted-by":"publisher","unstructured":"Elantary R, Othman S. Role of L-carnitine in Cardiovascular Health: Literature Review. Cureus. 2024, Sep, 26;16(9):e70279. https:\/\/doi.org\/10.7759\/cureus.70279. PMID: 39329040; PMCID: PMC11427024.","DOI":"10.7759\/cureus.70279"},{"key":"1235_CR28","doi-asserted-by":"crossref","unstructured":"Karwi QG, Uddin GM, Ho KL, Lopaschuk GD. Loss of metabolic flexibility in the failing heart. Frontiers in cardiovascular medicine. 2018. Jun, 6;5:68.","DOI":"10.3389\/fcvm.2018.00068"},{"issue":"1","key":"1235_CR29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1152\/physrev.00015.2009","volume":"90","author":"GD Lopaschuk","year":"2010","unstructured":"Lopaschuk GD, Ussher JR, Folmes CDL, Jaswal JS, Stanley WC. Myocardial fatty acid metabolism in health and disease. Physiol Rev. 2010, Jan;90(1):207\u201358. https:\/\/doi.org\/10.1152\/physrev.00015.2009.","journal-title":"Physiol Rev"},{"issue":"10","key":"1235_CR30","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","volume":"128","author":"GD Lopaschuk","year":"2021","unstructured":"Lopaschuk GD, Karwi QG, Tian R, Wende AR, Abel ED. Cardiac energy metabolism in heart failure. Circ Res. 2021, May, 14;128(10):1487\u2013513. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.318241.","journal-title":"Circ Res"},{"issue":"13","key":"1235_CR31","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","volume":"82","author":"P Skehan","year":"1990","unstructured":"Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst. 1990, Jul, 4;82(13):1107\u201312. https:\/\/doi.org\/10.1093\/jnci\/82.13.1107. PMID: 2359136.","journal-title":"J Natl Cancer Inst"},{"issue":"2018","key":"1235_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/4028297","volume":"2018","author":"F Vacante","year":"2018","unstructured":"Vacante F, Senesi P, Montesano A, Frigerio A, Luzi L, Terruzzi I. L-Carnitine: an antioxidant remedy for the survival of cardiomyocytes under hyperglycemic condition. J Diabetes Res. 2018, Dec;2018(2018):1\u201312. https:\/\/doi.org\/10.1155\/2018\/4028297. PMID: 30622968; PMCID: PMC6304876.","journal-title":"J Diabetes Res"},{"issue":"1","key":"1235_CR33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s12033-023-00731-0","volume":"66","author":"L Zhang","year":"2024","unstructured":"Zhang L, Xiu L, Wang T, Zhao D. Effect of L-carnitine in ameliorating lipopolysaccharide-induced cardiomyocyte injury via MAPK signaling. Mol Biotechnol. 2024, Jan;66(1):79\u201389. https:\/\/doi.org\/10.1007\/s12033-023-00731-0. Epub 2023 Apr 8. PMID: 37029860.","journal-title":"Mol Biotechnol"},{"key":"1235_CR34","doi-asserted-by":"publisher","unstructured":"Hsieh PH, Kacew AJ, Dreyer M, Serritella AV, Knoebel RW, Strohbehn GW, et al. Alternative trastuzumab dosing strategies in HER2-positive early breast cancer are associated with patient out-of-pocket savings. Npj Breast Cancer. 8(1). https:\/\/doi.org\/10.1038\/s41523-022-00393-2.","DOI":"10.1038\/s41523-022-00393-2"},{"issue":"11","key":"1235_CR35","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1093\/clinchem\/38.11.2203","volume":"38","author":"GS Bodor","year":"1992","unstructured":"Bodor GS, Porter S, Landt Y, Ladenson JH. The development of monoclonal antibodies and an assay for cardiac troponin I with preliminary results in suspected myocardial infarction. Clin Chem. 1992;38(11):2203\u201314. https:\/\/doi.org\/10.1093\/clinchem\/38.11.2203.","journal-title":"Clin Chem"},{"issue":"10","key":"1235_CR36","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1093\/clinchem\/28.10.2017","volume":"28","author":"AH Wu","year":"1982","unstructured":"Wu AH, Bowers GN Jr. Evaluation and comparison of immunoinhibition and immunoprecipitation methods for differentiating MB and BB from macro forms of creatine kinase isoenzymes in patients and healthy individuals. Clin Chem. 1982;28(10):2017\u201321. https:\/\/doi.org\/10.1093\/clinchem\/28.10.2017.","journal-title":"Clin Chem"},{"issue":"2","key":"1235_CR37","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1080\/15548627.2018.1516327","volume":"15","author":"F Arbogast","year":"2019","unstructured":"Arbogast F, Arnold J, Hammann P, Kuhn L, Chicher J, Murera D, et al. ATG5 is required for B cell polarization and presentation of particulate antigens. Autophagy. 2019, Feb;15(2):280\u201394. https:\/\/doi.org\/10.1080\/15548627.2018.1516327. Epub 2018 Sep 22. PMID: 30196744; PMCID: PMC6333460.","journal-title":"Autophagy"},{"issue":"7","key":"1235_CR38","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.str.2013.05.001","volume":"21","author":"DS Froese","year":"2013","unstructured":"Froese DS, Forouhar F, Tran TH, Vollmar M, Kim YS, Lew S, et al. Crystal structures of malonyl-coenzyme a decarboxylase provide insights into its catalytic mechanism and disease-causing mutations. Structure. 2013, Jul, 2;21(7):1182\u201392. https:\/\/doi.org\/10.1016\/j.str.2013.05.001. Epub 2013 Jun 20. PMID: 23791943; PMCID: PMC3701320.","journal-title":"Structure"},{"key":"1235_CR39","doi-asserted-by":"publisher","unstructured":"Ma L, Murea M, Snipes JA, Marinelarena A, Kr\u00fcger J, Hicks PJ, et al. An ACACB variant implicated in diabetic nephropathy associates with body mass index and gene expression in obese subjects. PLoS One. 2013;8(2):e56193. https:\/\/doi.org\/10.1371\/journal.pone.0056193. Epub 2013 Feb 27. PMID: 23460794; PMCID: PMC3584087.","DOI":"10.1371\/journal.pone.0056193"},{"issue":"1","key":"1235_CR40","doi-asserted-by":"publisher","first-page":"14118","DOI":"10.1038\/srep14118","volume":"5","author":"M Kashif","year":"2015","unstructured":"Kashif M, Andersson C, Hassan S, Karlsson H, Senkowski W, Frykn\u00e4s M, et al. In vitro discovery of promising anti-cancer drug combinations using iterative maximisation of a therapeutic index. Sci Rep. 2015, Sep;5(1):14118. https:\/\/doi.org\/10.1038\/srep14118. PMID: 26392291; PMCID: PMC4585751.","journal-title":"Sci Rep"},{"key":"1235_CR41","volume-title":"CompuSyn for drug combinations: PC software and user\u2019s guide: a computer program for quantitation of synergism and antagonism in drug combinations, and the determination of IC50, ED50, and LD50 values","author":"TC Chou","year":"2005","unstructured":"Chou TC, Martin N. CompuSyn for drug combinations: PC software and user\u2019s guide: a computer program for quantitation of synergism and antagonism in drug combinations, and the determination of IC50, ED50, and LD50 values. Paramus (NJ): ComboSyn Inc; 2005 [computer program."},{"issue":"10","key":"1235_CR42","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1038\/s41417-024-00819-y","volume":"31","author":"C Wang","year":"2024","unstructured":"Wang C, Bai C, Zhang Z, Zhou H, Gao H, Wang S, et al. UGT1A7 altered HER2-positive breast cancer response to trastuzumab by affecting epithelial-to-mesenchymal transition: a potential biomarker to identify patients resistant to trastuzumab treatment. Cancer Gene Ther. 2024;31(10):1525\u201335. https:\/\/doi.org\/10.1038\/s41417-024-00819-y.","journal-title":"Cancer Gene Ther"},{"key":"1235_CR43","doi-asserted-by":"publisher","unstructured":"Eaton H, Timm KN. Mechanisms of trastuzumab induced cardiotoxicity \u2013 is exercise a potential treatment? Cardio-Oncology. 2023;9(1). https:\/\/doi.org\/10.1186\/s40959-023-00172-3.","DOI":"10.1186\/s40959-023-00172-3"},{"issue":"7","key":"1235_CR44","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.3390\/ijms23074047","volume":"23","author":"A Panov","year":"2022","unstructured":"Panov A, Mayorov VI, Dikalov S. Metabolic syndrome and \u03b2-oxidation of long-Chain fatty acids in the brain, heart, and kidney mitochondria. Int J Mol Sci. 2022, Apr, 6;23(7):4047. https:\/\/doi.org\/10.3390\/ijms23074047. PMID: 35409406; PMCID: PMC9000033.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1235_CR45","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s12012-018-9500-0","volume":"19","author":"MM Sayed-Ahmed","year":"2019","unstructured":"Sayed-Ahmed MM, Alrufaiq BI, Alrikabi A, Abdullah ML, Hafez MM, Al-Shabanah OA. Carnitine supplementation attenuates sunitinib-induced inhibition of AMP-Activated protein kinase downstream signals in cardiac tissues. Cardiovasc Toxicol. 2019, Aug;19(4):344\u201356. https:\/\/doi.org\/10.1007\/s12012-018-9500-0. PMID: 30644033; PMCID: PMC6647422.","journal-title":"Cardiovasc Toxicol"},{"issue":"14","key":"1235_CR46","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1158\/1078-0432.CCR-16-2869","volume":"23","author":"V Narayan","year":"2017","unstructured":"Narayan V, Keefe S, Haas N, Wang L, Puzanov I, Putt M, et al. Prospective evaluation of sunitinib-induced cardiotoxicity in patients with metastatic renal cell carcinoma. Clin Cancer Res. 2017, Jul, 15;23(14):3601\u201309. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-2869. Epub 2017 Feb 14. PMID: 28196874; PMCID: PMC5516884.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1235_CR47","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1161\/01.CIR.88.1.101","volume":"88","author":"JE Adams 3rd","year":"1993","unstructured":"Adams JE 3rd, Bodor GS, Davila-Roman VG, Delmez JA, Apple FS, Ladenson JH, et al. Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation. 1993, Jul;88(1):101\u201306. https:\/\/doi.org\/10.1161\/01.CIR.88.1.101.","journal-title":"Circulation"},{"issue":"5","key":"1235_CR48","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/BF01931494","volume":"85","author":"GT Schuyler","year":"1990","unstructured":"Schuyler GT, Yarbrough LR. Changes in myosin and creatine kinase mRNA levels with cardiac hypertrophy and hypothyroidism. Basic Res Cardiol. 1990, Sep-Oct;85(5):481\u201394. https:\/\/doi.org\/10.1007\/BF01931494. PMID: 1703406.","journal-title":"Basic Res Cardiol"},{"issue":"1","key":"1235_CR49","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1475-2891-13-79","volume":"13","author":"BJ Lee","year":"2014","unstructured":"Lee BJ, Lin JS, Lin YC, Lin PT. Effects of L-carnitine supplementation on oxidative stress and antioxidant enzymes activities in patients with coronary artery disease: a randomized, placebo-controlled trial. Nutr J. 2014, Aug;13(1):79. https:\/\/doi.org\/10.1186\/1475-2891-13-79. PMID: 25092108; PMCID: PMC4125592.","journal-title":"Nutr J"},{"issue":"1","key":"1235_CR50","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3909\/ricm0710","volume":"15","author":"JJ DiNicolantonio","year":"2014","unstructured":"DiNicolantonio JJ, Niazi AK, McCarty MF, Lavie CJ, Liberopoulos E, O\u2019keefe JH. L-carnitine for the treatment of acute myocardial infarction. Rev Cardiovasc Med. 2014, Jan, 1;15(1):52\u201362. https:\/\/doi.org\/10.3909\/ricm0710.","journal-title":"Rev Cardiovasc Med"},{"issue":"18","key":"1235_CR51","doi-asserted-by":"publisher","first-page":"23026","DOI":"10.1007\/s11356-020-08919-6","volume":"27","author":"M Aboubakr","year":"2020","unstructured":"Aboubakr M, Elsayd F, Soliman A, Fadl SE, El-Shafey A, Abdelhiee EY. L-Carnitine and vitamin E ameliorate cardiotoxicity induced by tilmicosin in rats. Environ Sci Pollut Res. 2020, Jun;27(18):23026\u201334. https:\/\/doi.org\/10.1007\/s11356-020-08919-6.","journal-title":"Environ Sci Pollut Res"},{"key":"1235_CR52","doi-asserted-by":"publisher","unstructured":"Mansour HH, El Kiki SM, Ibrahim AB, Omran MM. Effect of l-carnitine on cardiotoxicity and apoptosis induced by imatinib through PDGF\/PPAR\u03b3\/MAPK pathways. Archives of biochemistry and biophysics. 2021. Jun, 15;704:108866. https:\/\/doi.org\/10.1016\/j.abb.2021.108866.","DOI":"10.1016\/j.abb.2021.108866"},{"key":"1235_CR53","doi-asserted-by":"publisher","unstructured":"Pauly DF, Pepine CJ. The role of carnitine in myocardial dysfunction. Am J Kidney Dis. 2003, Apr;41(4 Suppl 4):S35\u201343. https:\/\/doi.org\/10.1016\/s0272-6386(03)00115-x. PMID: 12751052.","DOI":"10.1016\/s0272-6386(03)00115-x"},{"issue":"7","key":"1235_CR54","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1158\/1541-7786.MCR-15-0068","volume":"13","author":"G Zadra","year":"2015","unstructured":"Zadra G, Batista JL, Loda M. Dissecting the dual role of AMPK in cancer: from experimental to human studies. Mol Cancer Res. 2015, Jul;13(7):1059\u201372. https:\/\/doi.org\/10.1158\/1541-7786.MCR-15-0068. Epub 2015 May 8. PMID: 25956158; PMCID: PMC4504770.","journal-title":"Mol Cancer Res"},{"key":"1235_CR55","doi-asserted-by":"publisher","unstructured":"Wang X, Yang C, Huang C, Wang W. Dysfunction of the carnitine cycle in tumor progression. Heliyon. 2024, Aug, 8;10(16):e35961. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e35961. PMID: 39211923; PMCID: PMC11357771.","DOI":"10.1016\/j.heliyon.2024.e35961"},{"issue":"5","key":"1235_CR56","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.3390\/ijms23052717","volume":"23","author":"MA Virmani","year":"2022","unstructured":"Virmani MA, Cirulli M. The role of l-carnitine in Mitochondria, prevention of metabolic inflexibility and disease initiation. Int J Mol Sci. 2022, Feb, 28;23(5):2717. https:\/\/doi.org\/10.3390\/ijms23052717. PMID: 35269860; PMCID: PMC8910660.","journal-title":"Int J Mol Sci"},{"key":"1235_CR57","doi-asserted-by":"publisher","first-page":"108125","DOI":"10.1016\/j.jmgm.2022.108125","volume":"112","author":"VG Lopes","year":"2022","unstructured":"Lopes VG, Filho ABC, Yoshinaga MY, Hirata MH, Ferreira GM. Carnitine palmitoyl transferase I: conformational changes induced by long-chain fatty acyl CoA ligands. J Mol Graph Model. 2022, May;112:108125. https:\/\/doi.org\/10.1016\/j.jmgm.2022.108125. Epub 2022 Jan 15. PMID: 35101729.","journal-title":"J Mol Graph Model"},{"issue":"2","key":"1235_CR58","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s003950050167","volume":"95","author":"M Calvani","year":"2000","unstructured":"Calvani M, Reda E, Arrigoni-Martelli E. Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions. Basic Res Cardiol. 2000, Apr;95(2):75\u201383. https:\/\/doi.org\/10.1007\/s003950050167.","journal-title":"Basic Res Cardiol"},{"issue":"25","key":"1235_CR59","doi-asserted-by":"publisher","first-page":"18212","DOI":"10.1074\/jbc.M700885200","volume":"282","author":"E L\u00f3pez-Vi\u00f1as","year":"2007","unstructured":"L\u00f3pez-Vi\u00f1as E, Bentebibel A, Gurunathan C, Morillas M, de Arriaga D, Serra D, et al. Definition by functional and structural analysis of two malonyl-CoA sites in carnitine palmitoyltransferase 1A. J Biol ChemJournal Biol Chem. 2007, Jun, 22;282(25):18212\u201324. https:\/\/doi.org\/10.1074\/jbc.M700885200. Epub 2007 Apr 23. PMID: 17452323.","journal-title":"J Biol ChemJournal Biol Chem"},{"issue":"6","key":"1235_CR60","doi-asserted-by":"publisher","first-page":"399","DOI":"10.4161\/epi.4.6.9767","volume":"4","author":"P Madiraju","year":"2009","unstructured":"Madiraju P, Pande SV, Prentki M, Madiraju SRM. Mitochondrial acetylcarnitine provides acetyl groups for nuclear histone acetylation. Epigenetics. 2009, Aug, 16;4(6):399\u2013403. https:\/\/doi.org\/10.4161\/epi.4.6.9767.","journal-title":"Epigenetics"},{"issue":"9","key":"1235_CR61","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.3390\/molecules25092127","volume":"25","author":"A Durazzo","year":"2020","unstructured":"Durazzo A, Lucarini M, Nazhand A, Souto SB, Silva AM, Severino P, et al. The nutraceutical value of carnitine and its use in dietary supplements. Molecules. 2020;25(9):2127. https:\/\/doi.org\/10.3390\/molecules25092127.","journal-title":"Molecules"},{"issue":"3","key":"1235_CR62","doi-asserted-by":"publisher","first-page":"212","DOI":"10.30773\/pi.2022.0255","volume":"20","author":"S Jeon","year":"2023","unstructured":"Jeon S, Park JE, Do YH, Santos R, Lee SM, Kim BN, et al. Atomoxetine and fluoxetine activate AMPK-ACC-CPT1 pathway in human SH-SY5Y and U-87 MG cells. Psychiatry Investigation. 2023, Mar;20(3):212\u201319. https:\/\/doi.org\/10.30773\/pi.2022.0255. Epub 2023 Mar 22. PMID: 36990664; PMCID: PMC10064201.","journal-title":"Psychiatry Investigation"},{"issue":"1","key":"1235_CR63","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1146\/annurev.biochem.67.1.821","volume":"67","author":"DG Hardie","year":"1998","unstructured":"Hardie DG, Carling D, Carlson M. The AMP-activated\/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu Rev Biochem. 1998;67(1):821\u201355. https:\/\/doi.org\/10.1146\/annurev.biochem.67.1.821. PMID: 9759505.","journal-title":"Annu Rev Biochem"},{"issue":"4","key":"1235_CR64","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrm3311","volume":"13","author":"DG Hardie","year":"2012","unstructured":"Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol. 2012, Mar, 22;13(4):251\u201362. https:\/\/doi.org\/10.1038\/nrm3311. PMID: 22436748; PMCID: PMC5726489.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"1235_CR65","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1432-1033.1997.00259.x","volume":"246","author":"DG Hardie","year":"1997","unstructured":"Hardie DG, Carling D. The AMP-activated protein kinase-fuel gauge of the mammalian cell? Eur J Biochem. 1997, Jun, 1;246(2):259\u201373. https:\/\/doi.org\/10.1111\/j.1432-1033.1997.00259.x. PMID: 9208914.","journal-title":"Eur J Biochem"},{"issue":"35","key":"1235_CR66","doi-asserted-by":"publisher","first-page":"22162","DOI":"10.1016\/S0021-9258(17)31770-2","volume":"269","author":"J Ha","year":"1994","unstructured":"Ha J, Daniel S, Broyles SS, Kim KH. Critical phosphorylation sites for acetyl-CoA carboxylase activity. J Biol ChemJournal Biol Chem. 1994, Sep, 2;269(35):22162\u201368. PMID: 7915280. https:\/\/doi.org\/10.1016\/S0021-9258(17)31770-2.","journal-title":"J Biol ChemJournal Biol Chem"},{"issue":"22","key":"1235_CR67","doi-asserted-by":"publisher","first-page":"8294","DOI":"10.1016\/S0021-9258(17)34395-8","volume":"253","author":"JD McGarry","year":"1978","unstructured":"McGarry JD, Takabayashi Y, Foster DW. The role of malonyl-coa in the coordination of fatty acid synthesis and oxidation in isolated rat hepatocytes. J Biol ChemJournal Biol Chem. 1978, Nov, 25;253(22):8294\u2013300. PMID: 711753. https:\/\/doi.org\/10.1016\/S0021-9258(17)34395-8.","journal-title":"J Biol ChemJournal Biol Chem"},{"issue":"12","key":"1235_CR68","doi-asserted-by":"publisher","first-page":"5166","DOI":"10.1210\/en.2003-0849","volume":"144","author":"NB Ruderman","year":"2003","unstructured":"Ruderman NB, Saha AK, Kraegen EW. Minireview: malonyl CoA, AMP-activated protein kinase, and adiposity. Endocrinology. 2003, Dec;144(12):5166\u201371. https:\/\/doi.org\/10.1210\/en.2003-0849. Epub 2003 Sep 18. PMID: 14500570.","journal-title":"Endocrinology"},{"issue":"2","key":"1235_CR69","first-page":"197","volume":"9","author":"H Zhao","year":"2017","unstructured":"Zhao H, Orhan YC, Zha X, Esencan E, Chatterton RT, Bulun SE. AMP-activated protein kinase and energy balance in breast cancer. Am J Transl Res. 2017, Feb, 15;9(2):197\u2013213. PMID: 28337254; PMCID: PMC5340661.","journal-title":"Am J Transl Res"},{"issue":"1","key":"1235_CR70","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/s0014-5793(03)00560-x","volume":"546","author":"DG Hardie","year":"2003","unstructured":"Hardie DG, Scott JW, Pan DA, Hudson ER. Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett. 2003, Jul, 3;546(1):113\u201320. https:\/\/doi.org\/10.1016\/s0014-5793(03)00560-x. PMID: 12829246.","journal-title":"FEBS Lett"},{"issue":"3","key":"1235_CR71","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.molcel.2005.03.027","volume":"18","author":"RG Jones","year":"2005","unstructured":"Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, Xu Y, et al. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell. 2005, Apr, 29;18(3):283\u201393. https:\/\/doi.org\/10.1016\/j.molcel.2005.03.027.","journal-title":"Mol Cell"},{"issue":"1","key":"1235_CR72","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.cmet.2012.12.001","volume":"17","author":"B Faubert","year":"2013","unstructured":"Faubert B, Boily G, Izreig S, Griss T, Samborska B, Dong Z, et al. AMPK is a negative regulator of the warburg effect and suppresses tumor growth in vivo. Cell MetabCell Metab. 2013, Jan, 8;17(1):113\u201324. https:\/\/doi.org\/10.1016\/j.cmet.2012.12.001. Epub 2012 Dec 27. PMID: 23274086; PMCID: PMC3545102.","journal-title":"Cell MetabCell Metab"},{"issue":"20","key":"1235_CR73","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1111\/febs.13391","volume":"282","author":"PN Gollavilli","year":"2015","unstructured":"Gollavilli PN, Kanugula AK, Koyyada R, Karnewar S, Neeli PK, Kotamraju S. AMPK inhibits MTDH expression via GSK3\u03b2 and SIRT1 activation: potential role in triple negative breast cancer cell proliferation. The FEBS J. 2015, Oct;282(20):3971\u201385. https:\/\/doi.org\/10.1111\/febs.13391. Epub 2015 Aug 20. PMID: 26236947.","journal-title":"The FEBS J"},{"key":"1235_CR74","doi-asserted-by":"publisher","unstructured":"Nagalingam A, Arbiser JL, Bonner MY, Saxena NK, Sharma D. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis. Breast Cancer Res. 14(1):R35. https:\/\/doi.org\/10.1186\/bcr3128. 2012 Feb 21. Erratum in:Breast Cancer Research.2017 Mar 28; 19(1):39. doi 10.1186\/s13058-017-0829-2. PMID: 22353783; PMCID: PMC3496153.","DOI":"10.1186\/bcr3128"},{"issue":"24","key":"1235_CR75","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.1128\/MCB.00579-15","volume":"35","author":"Y Tanaka","year":"2015","unstructured":"Tanaka Y, Yano H, Ogasawara S, Yoshioka S, Imamura H, Okamoto K, et al. Mild glucose starvation induces KDM2A-Mediated H3K36me2 demethylation through AMPK to reduce rRNA transcription and cell proliferation. Mol Cell Biol. 2015, Dec;35(24):4170\u201384. https:\/\/doi.org\/10.1128\/MCB.00579-15. Epub 2015 Sep 28. PMID: 26416883; PMCID: PMC4648824.","journal-title":"Mol Cell Biol"},{"issue":"19","key":"1235_CR76","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s11434-016-1129-4","volume":"61","author":"Y Chen","year":"2016","unstructured":"Chen Y, Li P. Fatty acid metabolism and cancer development. Sci Bull. 2016;61(19):1473\u201379. https:\/\/doi.org\/10.1007\/s11434-016-1129-4.","journal-title":"Sci Bull"},{"key":"1235_CR77","doi-asserted-by":"publisher","unstructured":"Locasale JW, C LC. Altered metabolism in cancer. BMC Biol. 2010, 8;8(1). https:\/\/doi.org\/10.1186\/1741-7007-8-88.","DOI":"10.1186\/1741-7007-8-88"},{"issue":"2023","key":"1235_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2023\/9328344","volume":"2023","author":"R Farahzadi","year":"2023","unstructured":"Farahzadi R, Hejazi MS, Molavi O, Pishgahzadeh E, Montazersaheb S, Jafari S. Clinical significance of carnitine in the treatment of cancer: from traffic to the regulation. Oxidative Med Cellular Longevity. 2023, Aug;2023(2023):1\u201315. https:\/\/doi.org\/10.1155\/2023\/9328344. PMID: 37600065; PMCID: PMC10435298.","journal-title":"Oxidative Med Cellular Longevity"},{"key":"1235_CR79","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.freeradbiomed.2023.06.019","volume":"206","author":"T Ye","year":"2023","unstructured":"Ye T, Yang W, Gao T, Yu X, Chen T, Yang Y, et al. Trastuzumab-induced cardiomyopathy via ferroptosis-mediated mitochondrial dysfunction. Free Radic Biol Med. 2023, Sep;206:143\u201361. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.06.019. Epub 2023 Jun 29. PMID: 37392951.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"1235_CR80","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/s41401-024-01397-3","volume":"46","author":"A De Bartolo","year":"2025","unstructured":"De Bartolo A, Romeo N, Marrone A, Rago V, Granieri MC, Vommaro ML, et al. A recombinant fragment antigen-binding (fab) of trastuzumab displays low cytotoxic profile in adult human cardiomyocytes: first evidence and the key implication of Fc\u03b3RIIA receptor. Acta Pharmacol Sin. 2025;46(3):618\u201331. PMID: 39414958 https:\/\/doi.org\/10.1038\/s41401-024-01397-3.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"1235_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/rp.59.1.1","volume":"59","author":"A Negro","year":"2004","unstructured":"Negro A. Essential roles of Her2\/erbB2 in cardiac development and function. Recent Prog Horm Res. 2004;59(1):1\u201312. https:\/\/doi.org\/10.1210\/rp.59.1.1. PMID: 14749494.","journal-title":"Recent Prog Horm Res"},{"issue":"4","key":"1235_CR82","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1074\/jbc.M804570200","volume":"284","author":"LI Gordon","year":"2009","unstructured":"Gordon LI, Burke MA, Singh ATK, Prachand S, Lieberman ED, Sun L, et al. Blockade of the erbB2 receptor induces cardiomyocyte death through mitochondrial and reactive oxygen species-dependent pathways. J Biol ChemJournal Biol Chem. 2009, Jan, 23;284(4):2080\u201387. https:\/\/doi.org\/10.1074\/jbc.M804570200. Epub 2008 Nov 18. PMID: 19017630; PMCID: PMC2629107.","journal-title":"J Biol ChemJournal Biol Chem"},{"issue":"1","key":"1235_CR83","first-page":"1005","volume":"2","author":"N Mohan","year":"2017","unstructured":"Mohan N, Jiang J, Wu WJ. Implications of autophagy and oxidative stress in Trastuzumab-mediated cardiac toxicities. Austin Pharmacol Pharm. 2017;2(1):1005. Epub 2017 Aug 15. PMID: 30288503; PMCID: PMC6168002.","journal-title":"Austin Pharmacol Pharm"},{"issue":"5","key":"1235_CR84","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/nm1574","volume":"13","author":"A Nakai","year":"2007","unstructured":"Nakai A, Yamaguchi O, Takeda T, Higuchi Y, Hikoso S, Taniike M, et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med. 2007, May;13(5):619\u201324. https:\/\/doi.org\/10.1038\/nm1574. Epub 2007 Apr 22. PMID: 17450150.","journal-title":"Nat Med"},{"issue":"1","key":"1235_CR85","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/BF02932962","volume":"43","author":"J D\u00e4mmrich","year":"1983","unstructured":"D\u00e4mmrich J, Pfeifer U. Cardiac hypertrophy in rats after supravalvular aortic constriction. II. Inhibition of cellular autophagy in hypertrophying cardiomyocytes. Virchows Arch B Cell Pathol. 1983;43(1):287\u2013307. https:\/\/doi.org\/10.1007\/BF02932962. PMID: 6137901.","journal-title":"Virchows Arch B Cell Pathol"},{"issue":"6798","key":"1235_CR86","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/35022595","volume":"406","author":"Y Tanaka","year":"2000","unstructured":"Tanaka Y, Guhde G, Suter A, Eskelinen EL, Hartmann D, L\u00fcllmann-Rauch R, et al. Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice. Nature. 2000, Aug, 24;406(6798):902\u201306. https:\/\/doi.org\/10.1038\/35022595. PMID: 10972293.","journal-title":"Nature"},{"issue":"28","key":"1235_CR87","doi-asserted-by":"publisher","first-page":"9745","DOI":"10.1073\/pnas.0706802105","volume":"105","author":"P Tannous","year":"2008","unstructured":"Tannous P, Zhu H, Johnstone JL, Shelton JM, Rajasekaran NS, Benjamin IJ, et al. Autophagy is an adaptive response in desmin-related cardiomyopathy. Proc Natl Acad Sci USA. 2008, Jul, 15;105(28):9745\u201350. https:\/\/doi.org\/10.1073\/pnas.0706802105. Epub 2008 Jul 9. PMID: 18621691; PMCID: PMC2474535.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1235_CR88","doi-asserted-by":"publisher","unstructured":"Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature. 469(7329):221\u201325. https:\/\/doi.org\/10.1038\/nature09663. 2011 Jan 13. Epub 2010 Dec 1.Erratum in:Nature.2011 Jul 7; 475,(7354):122. PMID: 21124315.","DOI":"10.1038\/nature09663"},{"issue":"1\u20133","key":"1235_CR89","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejphar.2010.01.017","volume":"632","author":"JL Miguel-Carrasco","year":"2010","unstructured":"Miguel-Carrasco JL, Monserrat MT, Mate A, Vazquez CM. Comparative effects of captopril and l-carnitine on blood pressure and antioxidant enzyme gene expression in the heart of spontaneously hypertensive rats. Eur J PharmacolEuropean J Pharmacol. 2010;632(1\u20133):65\u201372. https:\/\/doi.org\/10.1016\/j.ejphar.2010.01.017.","journal-title":"Eur J PharmacolEuropean J Pharmacol"},{"issue":"1","key":"1235_CR90","doi-asserted-by":"publisher","first-page":"4673","DOI":"10.1038\/s41598-022-08771-3","volume":"12","author":"Y-CG Lee","year":"2022","unstructured":"Lee Y-CG, Chou HC, Chen YT, Tung SY, Ko TL, Buyandelger B, et al. L-Carnitine reduces reactive oxygen species\/endoplasmic reticulum stress and maintains mitochondrial function during autophagy-mediated cell apoptosis in perfluorooctanesulfonate-treated renal tubular cells. Sci Rep. 2022, Mar, 18;12(1):4673. https:\/\/doi.org\/10.1038\/s41598-022-08771-3. PMID: 35304586; PMCID: PMC8933466.","journal-title":"Sci Rep"},{"issue":"4","key":"1235_CR91","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1177\/030089161309900418","volume":"99","author":"MM Sayed-Ahmed","year":"2013","unstructured":"Sayed-Ahmed MM, Hafez MM, Al-Shabanah OA, Al-Rejaie SS, Aleisa AM, Al-Yahya AA, et al. Increased expression of biological markers as potential therapeutic targets in Saudi women with triple-negative breast cancer. Tumori. 2013, Jul-Aug;99(4):545\u201354. https:\/\/doi.org\/10.1177\/030089161309900418. PMID: 24326846.","journal-title":"Tumori"},{"issue":"1","key":"1235_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tibs.2014.10.010","volume":"40","author":"SH Payne","year":"2015","unstructured":"Payne SH. The utility of protein and mRNA correlation. Trends Biochemical Sci. 2015, Jan;40(1):1\u20133. https:\/\/doi.org\/10.1016\/j.tibs.2014.10.010. Epub 2014 Nov 23. PMID: 25467744; PMCID: PMC4776753.","journal-title":"Trends Biochemical Sci"},{"issue":"5","key":"1235_CR93","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.cpt.2025.12.003","volume":"4","author":"H Chen","year":"2025","unstructured":"Chen H, Zhang L, Liu M, Li Y, Rao P. Multidimensional perspectives on cancer therapy-induced cardiotoxicity: characteristics, mechanisms, biomarkers, psychological stress effects, and treatment progress. Cancer Pathogen Ther. 2025;4(5):362\u201382. https:\/\/doi.org\/10.1016\/j.cpt.2025.12.003.","journal-title":"Cancer Pathogen Ther"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-026-01235-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-026-01235-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-026-01235-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:52:48Z","timestamp":1791888768000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40360-026-01235-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1235"],"URL":"https:\/\/doi.org\/10.1186\/s40360-026-01235-8","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"assertion":[{"value":"14 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All methods were carried out in accordance with institutional and national guidelines. All experimental protocols were ethically approved by the National Cancer Institute, Cairo University Institutional Review Board with approval number (CB2512-502\u2013138-205). The study used an established rat-derived cell line obtained from the American Type Culture Collection and did not involve human participants, human tissues, or live animals. Therefore, informed consent to participate was not applicable.","order":1,"name":"Ethics","label":"Ethical approval and consent to participants","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participants","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publications","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"140"}}